Credit Suisse’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-20,255
| Closed | -$244K | – | 3521 |
|
|
2019
Q1 | $244K | Buy |
20,255
+750
| +4% | +$9.04K | ﹤0.01% | 3112 |
|
|
2018
Q4 | $244K | Buy |
19,505
+988
| +5% | +$12.4K | ﹤0.01% | 3070 |
|
|
2018
Q3 | $274K | Sell |
18,517
-4,125
| -18% | -$61K | ﹤0.01% | 3092 |
|
|
2018
Q2 | $381K | Sell |
22,642
-89
| -0.4% | -$1.5K | ﹤0.01% | 3095 |
|
|
2018
Q1 | $520K | Sell |
22,731
-686
| -3% | -$15.7K | ﹤0.01% | 2928 |
|
|
2017
Q4 | $605K | Buy |
23,417
+9,726
| +71% | +$251K | ﹤0.01% | 2851 |
|
|
2017
Q3 | $202K | Buy |
+13,691
| New | +$202K | ﹤0.01% | 3441 |
|
|
2017
Q2 | – | Sell |
-29,327
| Closed | -$500K | – | 3524 |
|
|
2017
Q1 | $500K | Sell |
29,327
-3,865
| -12% | -$65.9K | ﹤0.01% | 2922 |
|
|
2016
Q4 | $341K | Sell |
33,192
-4,262
| -11% | -$43.8K | ﹤0.01% | 3246 |
|
|
2016
Q3 | $378K | Buy |
37,454
+2,560
| +7% | +$25.8K | ﹤0.01% | 3227 |
|
|
2016
Q2 | $392K | Buy |
34,894
+13,839
| +66% | +$155K | ﹤0.01% | 3260 |
|
|
2016
Q1 | $287K | Buy |
21,055
+6,570
| +45% | +$89.6K | ﹤0.01% | 3234 |
|
|
2015
Q4 | $275K | Sell |
14,485
-23,930
| -62% | -$454K | ﹤0.01% | 3508 |
|
|
2015
Q3 | $721K | Buy |
38,415
+11,244
| +41% | +$211K | ﹤0.01% | 2928 |
|
|
2015
Q2 | $404K | Sell |
27,171
-36,582
| -57% | -$544K | ﹤0.01% | 3576 |
|
|
2015
Q1 | $965K | Buy |
63,753
+39,094
| +159% | +$592K | ﹤0.01% | 2751 |
|
|
2014
Q4 | $329K | Buy |
24,659
+14,472
| +142% | +$193K | ﹤0.01% | 3629 |
|
|
2014
Q3 | $128K | Buy |
+10,187
| New | +$128K | ﹤0.01% | 3866 |
|
|
2014
Q2 | – | Sell |
-12,910
| Closed | -$174K | – | 4339 |
|
|
2014
Q1 | $174K | Buy |
+12,910
| New | +$174K | ﹤0.01% | 4023 |
|